
The FDA Peptide Vote: Why the 503A Recommendation is Not a Green Light | Client Alert
This is an important advisory for all practice owners and prescribing clinicians: an FDA advisory committee recently voted to recommend adding four peptides to the 503A bulk substances list, doing so over the explicit ob














